External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma by Milou M. F. Schuurbiers, Freek A. van Delft, Hendrik Koffijberg, Maarten J. IJzerman, Kim Monkhorst, Marjolijn J. L. Ligtenberg, Daan van den Broek, Huub H. van Rossum, Michel M. van den Heuvel

Get full text

Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease by Carina M. Behr, PhD, Maarten J. IJzerman, PhD, Michelle M.A. Kip, PhD, Harry J.M. Groen, MD, PhD, Marjolein A. Heuvelmans, MD, PhD, Maarten van den Berge, MD, PhD, Pim van der Harst, MD, PhD, Marleen Vonder, PhD, Rozemarijn Vliegenthart, MD, PhD, Hendrik Koffijberg, PhD

Get full text

Erratum to ‘Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease’... by Carina M. Behr, PhD, Maarten J. IJzerman, PhD, Michelle M.A. Kip, PhD, Harry J.M. Groen, MD, PhD, Marjolein A. Heuvelmans, MD, PhD, Maarten van den Berge, MD, PhD, Pim van der Harst, MD, PhD, Marleen Vonder, PhD, Rozemarijn Vliegenthart, MD, PhD, Hendrik Koffijberg, PhD

Get full text